Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-26T00:06:56.376Z Has data issue: false hasContentIssue false
  • English
  • Français

X-ray powder diffraction data for methoxmetamine hydrochloride, C14H20ClNO2

Published online by Cambridge University Press:  24 July 2018

Bronislav Jurasek Open the ORCID record for Bronislav Jurasek [Opens in a new window] ,
Martin Babor ,
Stepan Huber  and
Martin Kuchar
Bronislav Jurasek
Affiliation:
Department of Chemistry of Natural Compounds UCT Prague, Technická 5, Prague, 166 28, Czech Republic Forensic Laboratory of Biologically Active Substances UCT Prague, Technická 5, Prague, 166 28, Czech Republic
Martin Babor
Affiliation:
Department of Solid State Chemistry UCT Prague, Technická 5, Prague, 166 28, Czech Republic
Stepan Huber
Affiliation:
Department of Inorganic Chemistry UCT Prague, Technická 5, Prague, 166 28, Czech Republic
Martin Kuchar*
Affiliation:
Department of Chemistry of Natural Compounds UCT Prague, Technická 5, Prague, 166 28, Czech Republic Forensic Laboratory of Biologically Active Substances UCT Prague, Technická 5, Prague, 166 28, Czech Republic
*
a)Author to whom correspondence should be addressed. Electronic mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

X-ray powder diffraction data, unit-cell parameters and space group for methoxmetamine (C14H20ClNO2) are reported [a = 6.5768(7) Å, b = 14.0830(10) Å, c = 15.0530(10) Å, β = 90.975(2)°, unit-cell volume V = 1394.0(2) Å3, and Z = 4, and space group P21/n]. All measured lines were indexed and are consistent with the P21/n space group. No detectable impurities were observed.

Keywords

new psychoactive substancesX-ray powder diffractionmethoxmetaminedesigner drugsdissociative anesthetics
Type
New Diffraction Data
Information
Powder Diffraction , Volume 33 , Issue 3 , September 2018 , pp. 242 - 245
Check for updates
Copyright
Copyright © International Centre for Diffraction Data 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

de Wolff, P. M. (1968). “A simplified criterion for the reliability of a powder pattern,” J. Appl. Crystallogr. 1, 108–113.Google Scholar
EMCDDA (2014). Methoxetamine – Report on the Risk Assessment of 2-(3-Methoxyphenyl)-2-(Ethylamino)Cyclohexanone (Methoxetamine) in the Framework of the Council Decision on new Psychoactive Substances (Publications Office of the European Union, Luxembourg, Luxembourg).Google Scholar
EMCDDA (2016). European Drug Markets Report: In-Depth Analysis (Publications Office of the European Union, Luxembourg, Luxembourg).Google Scholar
EMCDDA and Europol (2017). European Drug Report: Trends and Developments (Publications Office of the European Union, Luxembourg, Luxembourg).Google Scholar
Fojtikova, L., Holubova, B., and Kuchar, M. (2017). “New psychoactive substances,” Chem. Listy 111, 234–238.Google Scholar
Hondebrink, L., Nugteren-van Lonkhuyzen, J. J., Van Der Gouwe, D., and Brunt, T. M. (2015). “Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre,” Drug Alcohol Depend. 147, 109–115.Google Scholar
Jurasek, B. and Kuchar, M. (2017). “Methoxfenidin,” Drugs Forensics Bull. 23, 3–7.Google Scholar
Jurasek, B., Himl, M., Jurok, R., Hajkova, K., Vobinuskova, A., Rezanka, P., and Kuchar, M. (2017). “Synthesis of methoxetamine, its metabolites and deuterium labelled analog as analytical standards and their HPLC and chiral capillary electrophoresis separation,” RSC Adv. 7, 56691–56696.Google Scholar
Páleníček, T., Lhotková, E., Žídková, M., Balíková, M., Kuchař, M., Himl, M., Mikšatkova, P., Čegan, M., Valeš, K., Tylš, F., and Horsley, R. R. (2016). “Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): pharmacokinetics, behaviour, thermoregulation and LD50 in rats,” Prog. Neuropsychopharmacol. Biol. Psychiatry 69, 49–59.Google Scholar
Smith, G. S. and Snyder, R. L. (1979). “FN: a criterion for rating powder diffraction pattern and evaluating the reliability of powder indexing,” J. Appl. Crystallogr. 12, 60–65.Google Scholar
Stevens, C. L. and Parke, D. (1966). “Aminoketones and methods for their production,” Patent US3254124.Google Scholar
Werner, P. E. (1964). “Trial-and-error computer methods for the indexing of unknown powder patterns,” Z. Kristallogr. – Cryst. Mater. 120, 375–387.Google Scholar
Zanda, M. T., Fadda, P., Chiamulera, C., Fratta, W., and Fattore, L. (2016). “Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects,” Behav. Pharmacol. 27, 489–496.Google Scholar
Supplementary material: File

Jurasek et al. supplementary material

Jurasek et al. supplementary material

Download Jurasek et al. supplementary material(File)
File 143.7 KB
Supplementary material: Image

Jurasek et al. supplementary material

Jurasek et al. supplementary material 2

Download Jurasek et al. supplementary material(Image)
Image 32 MB
Supplementary material: Image

Jurasek et al. supplementary material

Jurasek et al. supplementary material 3

Download Jurasek et al. supplementary material(Image)
Image 32 MB